Intestinal Parasites in Dogs and Cats: Identification, Symptoms, and Treatment Options

1. Introduction and Taxonomic Scope

Intestinal parasitism in domestic canids and felids represents a globally prevalent and clinically significant challenge in small animal veterinary medicine. The spectrum of etiologic agents encompasses a diverse array of phyla, including nematodes (roundworms), cestodes (tapeworms), trematodes (flukes), and multiple protozoan taxa. These organisms occupy distinct niches within the gastrointestinal tract, from the stomach and small intestine to the cecum and colon. The clinical consequences of infection range from subclinical carriage to severe enteropathy, malnutrition, anemia, and, in some cases, mortality, particularly in juvenile or immunocompromised hosts [1, 2]. Furthermore, many of these parasites possess zoonotic potential, representing a critical interface between companion animal health and public health [3, 4, 5].

This reference article provides a comprehensive, evidence-based review of the major intestinal parasites affecting dogs and cats. It focuses on the biological mechanisms of infection, diagnostic methodologies, clinical symptomatology, and current therapeutic options, with a strict emphasis on peer-reviewed veterinary literature. The discussion is organized by parasite group, with detailed subsections on life cycle biology, pathophysiological mechanisms, and treatment protocols.

2. Nematode Parasites

2.1 Ascarididae: Toxocara canis, Toxocara cati, and Toxascaris leonina

Ascarid nematodes are among the most common intestinal parasites of dogs and cats globally. Toxocara canis is the principal ascarid of canids, while Toxocara cati infects felids. Toxascaris leonina is a less host-specific ascarid found in both dogs and cats [86, 88]. The life cycles of these parasites are complex and involve multiple transmission routes, including direct ingestion of embryonated eggs, paratenic host ingestion, and, critically for T. canis, transplacental and transmammary transmission [60, 73].

Adult Toxocara spp. reside in the small intestinal lumen, where they compete with the host for nutrients. The pathogenesis of infection is multifactorial. Adult worms can cause mechanical obstruction, particularly in high-burden infections in puppies and kittens. The migratory larval stages, especially in paratenic hosts, can induce granulomatous inflammation in somatic tissues [60]. The clinical signs of ascarid infection include a pot-bellied appearance, poor coat condition, vomiting, diarrhea, and, in severe cases, intestinal obstruction [1]. Diagnosis is typically achieved via fecal flotation and identification of the characteristic thick-shelled, pitted eggs [6].

Treatment for ascarid infections in dogs and cats relies on the administration of anthelmintics such as pyrantel pamoate, fenbendazole, and moxidectin. Combination products containing fluralaner, moxidectin, and pyrantel have demonstrated high efficacy against T. canis and T. leonina in field studies [7, 8]. The zoonotic potential of T. canis is well documented, with human infection leading to visceral and ocular larva migrans [55].

2.2 Ancylostomatidae: Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, and Uncinaria stenocephala

Hookworms are blood-feeding nematodes of the small intestine that cause significant pathology through hematophagous activity. Ancylostoma caninum is the most prevalent and pathogenic species in dogs, while Ancylostoma braziliense and Ancylostoma ceylanicum are also reported in canids and felids [9, 10]. Uncinaria stenocephala is a less pathogenic hookworm species found predominantly in cooler climates [40].

The life cycle of hookworms involves direct percutaneous or oral infection with third-stage larvae (L3). In A. caninum, transmammary transmission is a major route of infection in neonatal puppies [10]. The pathogenesis of hookworm infection is directly linked to the attachment of adult worms to the intestinal mucosa, where they use cutting plates or teeth to lacerate tissue and ingest blood. This results in chronic blood loss, leading to iron-deficiency anemia, hypoproteinemia, and poor growth [66]. Clinical signs include pale mucous membranes, weakness, melena, and diarrhea [1].

Diagnosis is based on fecal flotation and identification of the thin-shelled, oval eggs. Molecular differentiation between A. caninum and U. stenocephala is possible using PCR-based assays [40]. Treatment involves the use of benzimidazoles (fenbendazole), macrocyclic lactones (moxidectin), or pyrantel pamoate. Combination products have shown high efficacy against hookworm infections [7, 8]. The zoonotic potential of A. caninum and A. ceylanicum is significant, as these species can cause cutaneous larva migrans and, in the case of A. caninum, eosinophilic enteritis in humans [9, 11].

2.3 Trichuris vulpis: Whipworm Infection

Trichuris vulpis is a whipworm that inhabits the cecum and colon of dogs. The life cycle is direct, with ingestion of embryonated eggs leading to larval development in the cecal mucosa. The pathogenesis of T. vulpis infection is associated with the mechanical irritation of the cecal and colonic mucosa by the adult worms, which embed their anterior ends in the tissue. This can lead to chronic inflammation, colitis, and diarrhea [1]. Clinical signs include mucoid or bloody diarrhea, tenesmus, and weight loss. Diagnosis is achieved via fecal flotation and identification of the characteristic bipolar, thick-shelled eggs. Treatment involves fenbendazole or milbemycin oxime.

2.4 Strongyloides stercoralis

Strongyloides stercoralis is a unique nematode with a complex life cycle involving both free-living and parasitic generations. It is a zoonotic parasite of significant concern, particularly in immunocompromised hosts [12, 13, 14]. In dogs, infection occurs primarily via percutaneous penetration of L3 larvae, which then migrate to the small intestine. The parasitic females are parthenogenetic and reside in the intestinal mucosa. The pathogenesis of S. stercoralis infection involves severe enteritis, with larval migration causing pulmonary and dermal pathology. Clinical signs include diarrhea, vomiting, weight loss, and, in severe cases, respiratory distress [14]. Diagnosis requires identification of rhabditiform larvae in fresh fecal samples, often using Baermann apparatus or direct smear. Treatment involves ivermectin or fenbendazole. The zoonotic potential is high, as S. stercoralis can cause severe, often fatal, hyperinfection syndrome in humans [12].

3. Cestode Parasites

3.1 Dipylidium caninum

Dipylidium caninum is the most common tapeworm of dogs and cats globally. The life cycle involves fleas (Ctenocephalides felis and Ctenocephalides canis) as the obligate intermediate host. Dogs and cats become infected by ingesting fleas containing the cysticercoid larvae. Adult tapeworms reside in the small intestine, where they shed proglottids that are passed in feces. The pathogenesis of D. caninum infection is generally mild, with clinical signs often limited to perianal pruritus and the observation of proglottids in feces or on the perineum [83]. Diagnosis is based on the identification of proglottids or the characteristic egg packets in fecal samples. Treatment involves praziquantel, which is effective against all cestode species.

3.2 Taenia spp. and Echinococcus spp.

Taenia species, including Taenia hydatigena and Taenia lynciscapreoli, are large tapeworms that infect dogs and cats through the ingestion of intermediate hosts such as rodents, lagomorphs, or ruminants [15]. Echinococcus granulosus is a small tapeworm of significant zoonotic concern, causing cystic echinococcosis in humans and livestock [16]. The life cycle of E. granulosus involves dogs as the definitive host and sheep or other ungulates as intermediate hosts. The pathogenesis of Echinococcus infection in dogs is typically subclinical, but the zoonotic potential is severe. Diagnosis of Echinococcus requires molecular confirmation, as eggs are morphologically indistinguishable from Taenia spp. [16]. Treatment involves praziquantel at appropriate dosages.

3.3 Spirometra spp. and Mesocestoides spp.

Spirometra species, including Spirometra erinaceieuropaei, are diphyllobothriid tapeworms that cause sparganosis in dogs and cats [15]. The life cycle involves copepod first intermediate hosts and paratenic hosts such as amphibians or reptiles. Mesocestoides species, including Mesocestoides vogae, can cause disseminated proliferative mesocestoidosis, a severe condition characterized by massive peritoneal and pleural cavity involvement [71]. The pathogenesis of these infections is associated with the proliferative capacity of the larval stages. Diagnosis requires molecular identification. Treatment is challenging and often involves high-dose praziquantel or surgical intervention [71].

4. Trematode Parasites

Trematode infections in dogs and cats are less common than nematode or cestode infections but are regionally important. Opisthorchis viverrini and Clonorchis sinensis are liver flukes that infect canids and felids through the ingestion of raw or undercooked fish [82]. The pathogenesis involves chronic inflammation of the bile ducts and can lead to cholangiocarcinoma. Diagnosis is based on fecal examination for operculated eggs. Treatment involves praziquantel.

5. Protozoan Parasites

5.1 Giardia duodenalis

Giardia duodenalis is a flagellated protozoan parasite that causes giardiasis in dogs and cats. It is a major cause of diarrhea in both species and is a significant zoonotic pathogen [17, 18, 19, 20]. The life cycle is direct, with infection occurring through the ingestion of cysts. The pathogenesis of G. duodenalis infection involves the attachment of trophozoites to the intestinal epithelium, causing villous atrophy, brush border damage, and malabsorption [21, 20]. Clinical signs include acute or chronic diarrhea, steatorrhea, vomiting, and weight loss [48]. Diagnosis is achieved through a combination of methods, including direct immunofluorescence assays (DFA), which are considered the gold standard [75], and enzyme-linked immunosorbent assays (ELISA) for antigen detection [17]. Molecular methods, such as PCR targeting the beta-giardin gene, are used for genotyping and zoonotic assemblage identification [18]. Treatment involves metronidazole, fenbendazole, or a combination of both [52]. Recurrence is common, and risk factors include environmental contamination and co-infections [41].

5.2 Cryptosporidium spp.

Cryptosporidium species, including Cryptosporidium canis and Cryptosporidium felis, are apicomplexan parasites that cause cryptosporidiosis in dogs and cats [22, 19]. The life cycle is direct, with infection occurring through the ingestion of oocysts. The pathogenesis involves the attachment of the parasite to the intestinal epithelium, causing villous atrophy and diarrhea. Clinical signs include watery diarrhea, vomiting, and weight loss, particularly in immunocompromised hosts [22]. Diagnosis is based on the detection of oocysts in fecal samples using modified acid-fast staining or DFA [75]. Molecular methods are used for species identification and zoonotic risk assessment [63]. Treatment is challenging, with drugs such as nitazoxanide or BKI-1708 showing efficacy in some studies [43].

5.3 Cystoisospora spp.

Cystoisospora species, including Cystoisospora canis and Cystoisospora felis, are coccidian parasites that cause coccidiosis in dogs and cats [45]. The life cycle is direct, with infection occurring through the ingestion of oocysts. The pathogenesis involves the invasion of the intestinal epithelium, causing enteritis and diarrhea. Clinical signs are most severe in juvenile animals. Diagnosis is based on the identification of oocysts in fecal samples. Treatment involves sulfonamides or toltrazuril.

5.4 Blastocystis sp.

Blastocystis is a protist parasite of uncertain pathogenicity that is frequently identified in fecal samples from dogs and cats [23]. The clinical significance of Blastocystis infection in companion animals is debated, with some studies suggesting an association with diarrhea and others finding no clear correlation [23]. The organism is transmitted via the fecal-oral route. Diagnosis is based on molecular methods, as morphological identification is challenging [69].

5.5 Dientamoeba fragilis

Dientamoeba fragilis is a flagellated protozoan parasite that has been identified in both human and veterinary specimens [59]. Its role in causing enteric disease in dogs and cats is not fully established, but it has been associated with diarrhea in some cases. Diagnosis requires molecular methods, as the organism is fragile and difficult to detect by conventional microscopy [59].

5.6 Enterocytozoon bieneusi

Enterocytozoon bieneusi is a microsporidian parasite that has been identified in dogs, particularly in shelter populations [44, 62]. It is a significant zoonotic pathogen, with multiple genotypes identified. The pathogenesis involves infection of the intestinal epithelium, causing diarrhea. Diagnosis requires molecular methods [44].

6. Diagnostic Approaches

The diagnosis of intestinal parasites in dogs and cats relies on a combination of methods, each with specific strengths and limitations. The choice of diagnostic approach depends on the clinical context, the suspected parasite, and the available laboratory resources.

6.1 Fecal Flotation

Fecal flotation is the most widely used method for the detection of nematode and cestode eggs. It relies on the use of a flotation solution with a specific gravity higher than that of the eggs, causing them to float to the surface. Common flotation solutions include zinc sulfate (specific gravity 1.18-1.20) and sodium nitrate (specific gravity 1.20-1.25). The sensitivity of fecal flotation is influenced by the egg density and the flotation solution used [6].

6.2 Direct Smear and Baermann Apparatus

Direct smear is useful for the detection of motile trophozoites, such as Giardia spp., and for the identification of Strongyloides larvae. The Baermann apparatus is a specialized technique for the recovery of Strongyloides and Dictyocaulus larvae from fecal samples [14].

6.3 Immunological Methods

Immunological methods, including ELISA for antigen detection and DFA for direct visualization, are the gold standard for the diagnosis of Giardia and Cryptosporidium infections [17]. These methods offer high sensitivity and specificity and are particularly useful for the detection of low-burden infections.

6.4 Molecular Methods

Molecular methods, including PCR and real-time PCR, offer the highest sensitivity and specificity for the detection of intestinal parasites. They are particularly valuable for the identification of species and genotypes that are morphologically indistinguishable, such as Giardia assemblages and Cryptosporidium species [18, 24]. Multiplex PCR assays have been developed for the simultaneous detection of multiple parasites [24].

6.5 Automated Systems

Automated systems, such as those using impedance-based analysis or image recognition, are increasingly used in veterinary diagnostics for the identification of parasite eggs and oocysts [42, 80]. These systems offer the potential for high-throughput analysis and reduced operator variability.

7. Treatment Options

The treatment of intestinal parasites in dogs and cats is guided by the specific etiologic agent, the clinical presentation, and the need to minimize zoonotic risk. A summary of common anthelmintic and antiprotozoal agents is provided in Table 1.

Table 1: Common Anthelmintic and Antiprotozoal Agents for Intestinal Parasites in Dogs and Cats

The selection of an appropriate therapeutic agent should be based on the specific parasite identified, the host species, and the potential for adverse effects. Combination products, such as those containing fluralaner, moxidectin, and pyrantel, offer broad-spectrum coverage and high efficacy [7, 8]. For protozoan infections, metronidazole and fenbendazole are the mainstays of therapy for Giardia [52], while Cryptosporidium treatment remains challenging [43].

8. Clinical Management and Prevention

The clinical management of intestinal parasitism in dogs and cats involves a combination of diagnostic confirmation, targeted therapy, and environmental control. Prevention strategies include regular fecal screening, routine anthelmintic administration, and the minimization of exposure to contaminated environments [25]. The role of owner education in the prevention of zoonotic transmission is critical [25].

9. Conclusion

Intestinal parasites in dogs and cats represent a diverse and clinically significant group of pathogens. The identification of these agents requires a combination of traditional and molecular diagnostic methods. Treatment is guided by the specific parasite and the clinical context. The zoonotic potential of many of these parasites underscores the importance of a One Health approach to their management.

References

[1] Schmid SM. Infectious Colitis in Dogs and Cats: Diagnosis, Management, and Clinical Outcomes. Vet Clin North Am Small Anim Pract. 2026.

[2] Bonatto G, Pandolfo GW, Fornara MA et al. Gastrointestinal helminthiases associated with cause of death in dogs and cats from southern Brazil. Vet Parasitol Reg Stud Reports. 2026.

[3] Gyarteng Mensah SS, Acheampong B, Streit A et al. Zoonotic Risk of Intestinal Parasites in Ghana's Protected Areas: A Nexus for Human-Nonhuman Primates-Dog Interactions. J Parasitol Res. 2026.

[4] Mahjoub HA. Intestinal zoonotic parasites in companion animals and potential of human exposure in the Middle East. Vet Parasitol Reg Stud Reports. 2026.

[5] Rivera DMF, Ballestas IT, Aleans MM et al. One Health assessment of zoonotic intestinal parasites in humans, dogs, and soil of coastal Cartagena, Colombia. Vet World. 2025.

[6] Hamel D, Lindner T, Rehbein S. Relationship between fecal egg counts and intestinal nematode burden of naturally infected dogs, derived from records of anthelmintic efficacy studies. Vet Parasitol. 2026.

[7] Chiummo R, Zschiesche E, Kirkova Z et al. Field study evaluating the efficacy of a combination formulation of fluralaner with moxidectin and pyrantel (BRAVECTO(®) TriUNO) against canine intestinal nematode infections. Parasit Vectors. 2026.

[8] Heinau L, Petersen I, Rohdich N et al. Efficacy evaluation of a new oral chewable tablet containing fluralaner, moxidectin, and pyrantel (BRAVECTO(®) TriUNO) against hookworm and Toxascaris leonina infections in a non-terminal study design in dogs. Parasit Vectors. 2026.

[9] Bradbury RS, Zendejas-Heredia PA, Truarn C et al. Human Intestinal Infection with the Dog Hookworm, Ancylostoma caninum, in Western Australia. Am J Trop Med Hyg. 2026.

[10] Mitrea IB, Iani AD, Gherman CM et al. Ancylostomatidae in wild canids and felids from Romania: new host associations and haplotype diversity. Parasit Vectors. 2026.

[11] Kelly MA, Anderson K, Castro PDJ et al. High prevalence of gastrointestinal parasites in dogs from Saipan, Northern Mariana Islands, including the zoonotic Ancylostoma ceylanicum. Parasit Vectors. 2026.

[12] Tobin EH, Meseeha M. Strongyloidiasis. PubMed. 2026.

[13] Chong J, Šlapeta J, Meggiolaro MN et al. Retrospective screening reveals the rare occurrence of zoonotic Strongyloides stercoralis in dogs from temperate Australia, 2014-2024. Parasitology. 2026.

[14] Chen Y, Slocombe R, Gauci C et al. Severe Strongyloides stercoralis infection in a puppy from a metropolitan area of Melbourne, Australia: a need for heightened awareness of this zoonotic parasite. Aust Vet J. 2026.

[15] Abdelhamid M, Thabit H, Elmaleck BSA et al. First molecular identification of Spirometra erinaceieuropaei, Ligula intestinalis, and Taenia hydatigena infecting wildlife canine and avian hosts from the Astrakhan Region, Russia. Vet Parasitol Reg Stud Reports. 2026.

[16] Shao G, Zhu X, Hua R et al. Oral administration of recombinant Bacillus subtilis spores induces protective immunity against Echinococcus granulosus infection in dogs. Parasit Vectors. 2025.

[17] Li X, Browne KA, Dong C et al. AN AUTOMATED CHEMILUMINESCENCE IMMUNOASSAY FOR DETECTION OF GIARDIA DUODENALIS ANTIGENS FROM CANINE SPECIMENS. J Parasitol. 2026.

[18] Scorza AV, Leutenegger CM, Lozoya C et al. Comparison of multilocus genotyping and a commercial beta-giardin qPCR assay for detection of Giardia duodenalis zoonotic assemblages in cat and dog samples. Parasit Vectors. 2026.

[19] Nahar A, Hasan MF, Harun AB et al. Molecular detection and zoonotic potential of Cryptosporidium spp. and Giardia duodenalis in cats and dogs from metropolitan areas of Bangladesh. Food Waterborne Parasitol. 2026.

[20] Decorte B, Claerebout E, Geldhof P. Chronic Giardia infections in dogs: Longitudinal analysis of cyst excretion and fecal consistency in young and adult dogs. Vet Parasitol. 2026.

[21] Polack B, Thomas M, Wu-Chuang A et al. Impact of Lactobacillus johnsonii CNCM I-4884 on canine giardiasis: a probiotic-based approach. Parasit Vectors. 2025.

[22] Cao R, Li D, Zhou Y et al. Zoonotic Transmission Assessment of Cryptosporidium spp. in Close Human-Pet Environments in Yunnan Province, China. Vet Med Sci. 2026.

[23] Makouloutou-Nzassi P, Longo-Pendy NM, Atome GN et al. Prevalence and Genetic Diversity of Blastocystis sp. in Humans, Dogs and Cats in Gabon: A One Health Perspective. Zoonoses Public Health. 2026.

[24] Chen G, Wang F, Xu B et al. Integrated PCR-Based Molecular Detection System for the Simultaneous Detection of Four Zoonotic Intestinal Parasites from Multiple Sources. J Vis Exp. 2025.

[25] Islam S, Hasan R, Islam S et al. Assessment of Pet Owners' Knowledge on Parasitic Infection in Sylhet City Corporation, Bangladesh. J Parasitol Res. 2026.

[26] Sabetti MC, Corsini A, Colosini M et al. Peripheral blood eosinophilia in dogs and cats: A cross-sectional study on prevalence, seasonality, and endoparasite infections in a referral hospital population. Res Vet Sci. 2026.

[27] Santos ACID, Malheiros AF, Barros LF et al. Cross-species transmission of gastrointestinal parasites between wild and domestic canids. Rev Bras Parasitol Vet. 2026.

[28] Rajpoot P, Singh M, Shakya M et al. Percent positivity and risk analysis of zoonotic intestinal parasites (helminths) in dogs population- a participatory epidemiological study. Vet Parasitol Reg Stud Reports. 2026.

[29] Defourny SVP, Colombo M, D'Amico G et al. Parasitic surveillance in wolves of central Italy: a focus on the Abruzzo region. Parasit Vectors. 2026.

[30] Low SY, Gun SK, Babatunde SM et al. Public Spaces as Hotspots of Zoonotic Gastrointestinal Parasite Transmission: Evidence from Small Animal and Soil Surveillance in Malaysia. J Epidemiol Glob Health. 2026.

[31] Barrera JP, Montoya A, Marino V et al. Intestinal parasite prevalences in dogs and cats: a decade of retrospective data from a reference veterinary laboratory in Madrid, Spain. Parasit Vectors. 2025.

[32] Severino AJM, Gomes DS, Costa AT et al. Intestinal parasites in dogs and their association with clinical manifestations of canine visceral leishmaniasis. Vet Parasitol. 2026.

[33] Rai P, Ghimire TR. Intestinal Parasites of Zoonotic Significance in Human and Domestic Animals in a Rural Setting in Nepal. Vet Med Sci. 2026.

[34] Mengistu GA, Atickem A, Kebede N et al. Incidence of gastrointestinal helminth parasites of free-ranging domestic dogs from the web valley, Bale mountains National park, Ethiopia. BMC Vet Res. 2025.

[35] Bayazid AA, Hasan MF, Sutradhar S et al. Prevalence, risk factors, and zoonotic implications of gastrointestinal parasites in dogs and cats in Dhaka City, Bangladesh. Vet Parasitol Reg Stud Reports. 2025.

[36] Teixeira R, Flor I, Nunes T et al. Assessing the effects of seasonal variation and climatic factors on gastrointestinal and pulmonary parasitism in dogs and cats from the Azores archipelago - Portugal. Parasitol Int. 2026.

[37] Bakhshani A, Razmi G. Gastrointestinal parasites in shelter dogs in Khorasan Razavi province, Iran: prevalence and mini review in Iran and some neighboring countries. Vet Res Forum. 2025. 38 *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic management.